A previously healthy 6-year-old boy was referred to our hospital with a tumor in the right upper mediastinum on chest X-ray. Physical examination showed no abnormal respiratory sounds, hepatosplenomegaly, or palpable tumor. On MRI, a right mediastinal tumor, 37 × 38 × 25 mm in size, with low intensity on T1-weighted images and high intensity on T2-weighted images was seen. A left-sided cervical mass, 27 × 29 × 10 mm in size, and several small lesions were seen in the liver and kidneys; all were of intensities similar to those of the mediastinal tumor (Fig. 1a, b). On histopathological examination of the biopsied samples from the mediastinal tumor, diffuse proliferation of medium-sized atypical lymphocytes with scant cytoplasm and fine chromatin was seen (Fig. 2); immunohistochemistry was positive for CD79a, CD10, and CD34, and negative for CD3, CD7, and CD20. Bone marrow aspiration showed a normocellular marrow with 5.4% lymphoblasts, suggesting involvement of lymphoma cells. These findings led to a diagnosis of precursor B-cell lymphoblastic lymphoma (LBL) stage IV.
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.